Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on April 14, 2025

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety

FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety

BOCA RATON, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that HiCentral MLS® will offer FOREWARN® services to …

CBAK Partners with Kandi to Localize Lithium Battery Facilities in the U.S. in Phases

CBAK Partners with Kandi to Localize Lithium Battery Facilities in the U.S. in Phases

DALIAN, China, April 14, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”) a leading lithium-ion battery manufacturer and electric energy solution provider in China, jointly with Kandi Technologies Group …

MKS Instruments Announces First Quarter 2025 Earnings Conference Call

MKS Instruments Announces First Quarter 2025 Earnings Conference Call

ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …

Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)

Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)

–   Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process –   RMAT review by FDA included initial clinical safety and activity data from ongoing …

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

 – $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue- …

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced expected revenue and …

Western Uranium & Vanadium Corp. Announces Ore Purchase Agreement

Western Uranium & Vanadium Corp. Announces Ore Purchase Agreement

Toronto, Ontario and Nucla, Colorado, April 14, 2025 (GLOBE NEWSWIRE) -- Western Uranium …

Bitcoin 2.0: BloomBeans Offers $150M Airdrop for a New Economic Foundation

Bitcoin 2.0: BloomBeans Offers $150M Airdrop for a New Economic Foundation

Lisbon, Portugal, April 14, 2025 (GLOBE NEWSWIRE) -- BloomBeans.io is releasing the first decentraliced financial system to substitute Bitcoin. A New Global Financial System Lead by Takashi Nakamoto and designed by Austrian economists, BloomBeans operates …

NowVertical to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025

NowVertical to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025

TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership …

Volatus Aerospace Obtient une Prolongation de son Entente de Services avec le Gouvernement du Canada

Volatus Aerospace Obtient une Prolongation de son Entente de Services avec le Gouvernement du Canada

MONTRÉAL, 14 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : A2JEQU) (« Volatus » ou la « Société »), chef de file en solutions aériennes, annonce fièrement la prolongation d’un an, soit la durée maximale …

Volatus Aerospace Secures Extension to Service Agreement with Canadian Government

Volatus Aerospace Secures Extension to Service Agreement with Canadian Government

MONTREAL, April 14, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (Frankfurt: A2JEQU) ("Volatus" or "the Company"), a leader in aerial solutions, proudly announces a one-year extension, the maximum allowable, to its Public …

Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated

Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated

LONDON and AMSTERDAM, April 14, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle computer resources across multiple DePINs (Decentralized Physical Infrastructure Networks), has officially integrated Swarm …

Qorvo® Announces Results of Board Refreshment Process

Qorvo® Announces Results of Board Refreshment Process

Appoints Richard L. Clemmer and Christopher R. Koopmans as Independent Directors David H. Y. Ho to Retire from the Board GREENSBORO, N.C., April 14, 2025 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power …

Relmada Therapeutics To Present NDV-01 Data at AUA2025

Relmada Therapeutics To Present NDV-01 Data at AUA2025

CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …

Dragonfly Energy’s Battle Born® Mobile App Now Available for Android Users

Dragonfly Energy’s Battle Born® Mobile App Now Available for Android Users

RENO, Nev., April 14, 2025 (GLOBE NEWSWIRE) -- Android users can now wirelessly monitor and manage their Battle Born® smart battery systems through the newly released Battle Born Mobile App, available on the Google Play Store. Developed by Dragonfly Energy …

American Tungsten Corp. Announces New CEO, Ali Haji

American Tungsten Corp. Announces New CEO, Ali Haji

Vancouver, BC, April 14, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) today announces that Ali Haji has been appointed as Chief Executive Officer. Murray Nye will assume the role …

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value Rights …

Avicanna Reports Full Year 2024 Audited Financial Statement

Avicanna Reports Full Year 2024 Audited Financial Statement

2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: …

SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)

SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service